Protalix BioTherapeutics (PLX) Change in Cash (2010 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Change in Cash of $26.3 million for Q1 2026, up 8815.56% year-over-year from $295225.3 in Q1 2025, and up 2448.02% quarter-over-quarter from $1.0 million in Q4 2025.
Protalix BioTherapeutics (PLX) Change in Cash (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at $26.3 million for Q1 2026.
- In Q1 2026, Change in Cash rose 8815.56% year-over-year to $26.3 million; the TTM figure through Mar 2026 stood at $21.5 million (up 377.94% YoY), while the FY2025 annual figure was -$5.1 million, down 31.13% from the prior year.
- Change in Cash for Q1 2026 stood at $26.3 million, up from $1.0 million in the prior quarter.
- The five-year high for Change in Cash was $26.3 million in Q1 2026, with the low at -$27.8 million in Q3 2023.
- The 5-year median for Change in Cash is -$302000.0 (2025), against an average of $118588.2.
- The sharpest annual moves came in 2022 and 2026: Change in Cash slumped 1511.95% in 2022, then surged 8815.56% in 2026.
- Protalix BioTherapeutics' Change in Cash stood at $6.4 million in 2022, then plunged by 49.52% to $3.2 million in 2023, then slumped by 337.1% to -$7.6 million in 2024, then jumped by 113.51% to $1.0 million in 2025, then jumped by 2448.02% to $26.3 million in 2026.
- Business Quant data shows PLX's Change in Cash at $26.3 million in Q1 2026, $1.0 million in Q4 2025, and -$4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Protalix BioTherapeutics | 189.97 Mn | 149.31 Mn | 12.13 Mn | -13.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.58 Mn |
| Mar 31, 2026 | 26.32 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | -4.25 Mn |
| Jun 30, 2025 | -1.56 Mn |
| Mar 31, 2025 | -302,000.00 |
| Dec 31, 2024 | -7.65 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | -3.81 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | -27.78 Mn |
| Jun 30, 2023 | 15.15 Mn |
| Mar 31, 2023 | 15.93 Mn |
| Dec 31, 2022 | 6.39 Mn |
| Sep 30, 2022 | -1.77 Mn |
| Jun 30, 2022 | -4.40 Mn |
| Mar 31, 2022 | -22.10 Mn |
| Dec 31, 2021 | 28.34 Mn |
| Sep 30, 2021 | -23.24 Mn |